ViewNvivo would be suitable for all ex-vivo applications being explored and with better image quality would certainly be a player in the "pathology in the operating room" space saving time and money for doctors and hospitals as well as faster diagnosis for patients.
http://finance.yahoo.com/news/mauna-kea-technologies-persee-study-174600035.html
"Cellvizio provided ex-vivo images of excised lesions that were analyzed by surgeons, pathologists and physicists and compared to histology standard of care. Diagnosis was complete using both traditional and new remote digital pathology methods".
ViewNvivo would be suitable for all ex-vivo applications being...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $463 | 2.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 46748 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 46940 | 2 |
View Market Depth
| Last trade - 12.18pm 02/12/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
